DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Recs

0
Player Avatar pbk100 (29.50) Submitted: 5/20/2011 11:07:05 PM : Outperform Start Price: $8.09 DEPO Score: -32.23

Magic Formula. Insider buying. Plenty of cash and proven ability to bring in money through partnering.

Featured Broker Partners


Advertisement